The aim of this study was to compare the results of the 44-h ambulatory blood pressure monitoring (ABPM) data between haemodialysis (HDp) and CAPD patients and to investigate the relation of circadian rhythm in blood pressure (BP) with development of left ventricular hypertrophy. Twenty-two HDp (11 male, 11 female, mean age: 50 ± 17 years) and 24 CAPDp (11 male, 13 female, mean age: 47 ± 15 years) were included. Echocardiographic measurements and ABPM were performed in all study groups. ABPM of the first and second days were analysed separately and compared with CAPDp. Left ventricular hypertrophy was detected in 17 of the 22 HDp (77%) and 17 of the 24 CAPDp (71%). There was no significant differences between HD and CAPDp in respect to 44-h, daytime and night-time systolic and diastolic BP values. Although the course of BP in CAPDp was stable during the 44-h period, systolic and diastolic BP levels on the second day were significantly higher than those of on the first day in HDp (P Ͻ 0.001
Introduction
Hypertension in dialysis patients is an important risk factor for development of left ventricular hypertrophy (LVH) and for increased cardiovascular mortality. The main reason for hypertension in dialysis patients is volume overload. [1] [2] [3] Haemodialysis is an intermittent type of renal replacement treatment, whereas patients with continuous ambulatory peritoneal dialysis (CAPD) have steady-state volume condition. Increased dietary Na intake, overestimation of the patient's dry weight and inadequate ultrafiltration by the peritoneum have been implicated for volume overload in dialysis patients. It has been reported that ambulatory blood pressure monitoring (ABPM) data in dialysis patients are a better predictor for development of LVH and cardiovascular mortality than casual blood pressure (BP) measurements. 4, 5 Casual BP measurements are far from being ideal to reflect BP levels precisely in dialysis patients and adjusting antihypertensive treatment according to casual BP measurements may cause an inadequate BP control. ABPM allows a better assessment in the course of BP levels during the day. 5, 6 It was also reported that abnormal BP rhythm, which is common in patients with endstage renal failure, might be associated with target organ damage resulting from hypertension in women. 7 Numerous studies with 24-h ABPM have been reported in haemodialysis and CAPD patients. However, there are limited numbers of studies comparing haemodialysis and CAPD treatments in respect to BP control by using ABPM over a longer period of time. 8, 9 The aim of this study was to compare the results of the 44-h ABPM data between haemodialysis and CAPD patients and to investigate the relation of circadian rhythm in BP with development of LVH.
Patients and methods
Twenty-two HD patients (11 male, 11 female, mean age: 50 ± 17 years) and 24 CAPD patients (11 male, 13 female, mean age: 47 ± 15 years) were included. There was no difference in mean time on dialysis between haemodialysis and CAPD patients (32 ± 26 vs 22 ± 18 months, P = NS). All dialysis patients had been dialyzed in the daytime (first session of the day) for more than 6 months. There was no difference in age, gender, rate of erythropoietin use and primary cause of ESRD between study groups. All haemodialysis patients have been dialyzed thrice weekly and the duration of dialysis was 4 h per session with bicarbonate containing dialysate bath. Blood flow rate was 250-300 ml/min with a dialysate flow of 500 ml/min.
All CAPD patients performed standard peritoneal dialysis (four daily exchanges of 2 liters each, 1.36% glucose three times and 3.86% once). None of the CAPD patients had ultrafiltration failure (less than 400 ml of net ultrafiltration in a 4 h dwell with 2 litres 3.86% glucose solution). Daily urine volume of all CAPD patients were under 200 ml. The patients with recent past history of peritonitis (within 3 months) and congestive heart failure were excluded from the study. All dialysis patients were on sodium restricted (2 g/day) and 1.2 g/kg/day protein diet. Antihypertensive drugs were discontinued for 2 weeks. Mean KT/V value in haemodialysis patients was 1.32 ± 0.33 for each session and weekly KT/V in CAPD patients was 1.91 ± 0.44. There was no change in body weight of the patients during the last 4 weeks. Demographic features of the haemodialysis and CAPD patients are given in Table 1 .
All the patients were examined with good medical and laboratory practice according to the recommendations set forth by the Declaration of Helsinki on Biomedical Research involving Human Subjects.
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Echocardiographic examination
Echocardiographic examination was carried out with a ATL 5000 echocardiographic system equipped with 2-4 mHz phased assay transducer. Echocardiographic parameters were taken the day after haemodialysis for haemodialysis patients and with empty abdomen for CAPD patients. M Mode and two-dimensional measurements were done in accordance to methods recommended by American Society of Echocardiography. 11, 12 Criteria for LVH was left ventricular mass index (LVMI) Ͼ134 g/m 2 for males and Ͼ110 g/m 2 for females. 13 The cardiac mass was calculated by the formula derived by Reichek and Devereux; 14 Left ventricle mass (g) = 1.04
Cardiac mass was standardised by dividing it to body surface area, which was calculated using Du Bois formula:
Body surface area = (weight 0.425 × height 0.725 × 0.007184).
Ambulatory blood pressure monitoring
ABPM using a non-invasive ABP monitor (GH Medical Inc, patient monitor) was started at the end of mid-week haemodialysis session and continued until the beginning of next dialysis session. The monitor was programmed to perform readings at 15-min intervals between 6 am and 10 pm (daytime), and at 30-min intervals between 10 pm and 6 am (night-time).
Mean BP levels that exceeded 135/85 mm Hg were considered as hypertension. The patients whose night-time mean BP levels drop less than 10% compared with the daytime period were accepted as a non-dipper. 15 
Statistics
Statistical analyses were performed with the statistical package program for social sciences (SPSS for Windows 10.0, Chicago, III, USA). Values are given mean ± s.d. Comparisons between groups were made by paired and unpaired t-test when appropriate. When the data were not normally distributed, non-parametric tests were used. Chi-square test with Yates correction and Fisher's exact test were used for 2 × 2 contingency tables when appropriate for non-numerical data. Correlations between numerical parameters were analysed with Spearman's rho bivariate correlation test. P values less than 0.05 were accepted as significant.
Results
The results of the echocardiographic examination are given in Table 1 . LVH was detected in 17 of the 22 haemodialysis (77%) and 17 of the 24 CAPD (71%) patients. The results of the ABPM measurements were given in Table 2 . There were no significant differences between haemodialysis and CAPD patients in respect to 44-h, daytime and night-time systolic and diastolic BP values. According to the entire period (44-h) records, 10 of the 22 (46%) haemodialysis patients and 11 of the 24 (46%) CAPD patients were found to be hypertensive. Ambulatory BP measurements of the first and second days were analysed separately. The ratio of hypertensive patients in the haemodialysis group was lower than that of CAPD patients on the first 587 day (27% and 54%, P = 0.08), despite not reaching statistically significant levels. On the second day, the ratio of hypertension in the haemodialysis group was significantly higher than CAPD group (77% and 42%, P = 0.02). Although the course of BP in CAPD patients was stable during the 44-h period, systolic and diastolic BP levels on the second day were significantly higher than those of on the first day in the haemodialysis patients (P Ͻ 0.001 for both). Daytime systolic and diastolic BP levels at the first day in the haemodialysis group were recorded lower than those of the CAPD group. However, there was no difference in night-time systolic and diastolic BP between patients with haemodialysis and CAPD at the first day. At the second day, night-time BP readings (both systolic and diastolic BP) were measured significantly higher in the haemodialysis group compared with the CAPD group, despite these being no difference in daytime BP levels between the haemodialysis and CAPD groups ( Table 2) . Mean interdialytic weight gain in the haemodialysis patients was 2.6 ± 0.9 kg. There was a significant positive correlation between mean systolic BP level during a 44-h period and the body weight gained in the interdialytic period in haemodialysis patients (r = 0.78, P Ͻ 0.05).
On comparing patients with and without LVH, all BP parameters in ABPM analysis were significantly increased in patients with LVH (Table 3) .
On analysis for circadian rhythm of BP, according to 44-h recording, 21 of the 24 (88%) CAPD patients were dipper, whereas only four of the 22 (18%) haemodialysis patients were dipper (P Ͻ 0.001). There was no difference in time on dialysis between dipper and non-dipper patients (23 ± 21 vs 32 ± 26 months, P = 0.21). On comparing the dipper rate between first and second day of dialysis, no difference was found in both CAPD (21/24 vs 21/24, respectively) and haemodialysis (2/22 vs 5/22, P = 0.41, respectively) patients. Dipper patients had lower LVMI than non-dipper patients in both haemodialysis (121 ± 29 g/m 2 vs 155 ± 40 g/m 2 , P = 0.12) and CAPD patients (133 ± 30 g/m 2 vs 143 ± 48 g/m 2 , P = 0.62), but the difference did not reach significant levels. However, when combining haemodialysis and CAPD patients, dipper patients had lower LVMI than non-dipper patients (131 ± 29 g/m 2 vs 153 ± 40 g/m 2 , P = 0.03) (Figure 1 ).
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Discussion
Hypertension is common in dialysis population and hypervolaemia is the most important implicated fac- tor in these patients. Blood pressure shows a steadystate course in CAPD patients, however it shows intermittent changes in haemodialysis patients, due to changes in volume status with intermittent ultrafiltration. In our study, no difference in daytime and night-time systolic and diastolic blood pressures was found between haemodialysis and CAPD patients in a 44-h BP monitoring. The ratio of hypertensive patients in the haemodialysis and CAPD groups was also similar in 44-h ABPM analysis (28% and 32%, respectively). In most of the comparative studies for BP control, it was reported that hypertension is better controlled by haemodialysis than CAPD. 6, 8, 16 However, Rodby et al 9 reported haemodialysis is associated with higher systolic blood pressures than peritoneal dialysis. The differences in the results of the studies are probably due to the differences in volume status of the patients.
On comparison of the BP data of ABPM between the first and second day of follow-up, there were no significant changes in BP parameters between first and second day in CAPD. However, haemodialysis patients showed significant changes between the first and second day of monitoring as expected. On the first day, daytime systolic and diastolic blood pressures in haemodialysis patients were found to be decreased as compared with CAPD patients, probably due to volume decrease. Hence, rate of hypertension in haemodialysis patients is lower than CAPD in the first day of monitoring (8% vs 32%, P = 0.02). Our results were consistent with results by the Coomer et al. 8 It could be proposed that haemodialysis has less cardiovascular risk regarding BP characteristics as compared with CAPD at the first day of haemodialysis. However, the circadian BP rhythm, which is reported as another predictor of cardiac mortality, 17, 18 is more deteriorated in the first day in haemodialysis patients as compared with CAPD patients.
There are conflicting reports about the effect of dialysis modality on circadian rhythm of BP. Korzets et al 19 reported a preserved circadian pattern of BP in 21 of 31 CAPD patients. Similarly, Rodby et al 9 also noted that diurnal variation was maintained in both haemodialysis and CAPD patients. In contrast to these findings, a number of studies reported low prevalence of diurnal variation of BP in both groups. 8, 20, 21 In our study, the rate of non-dippers was found to be significantly higher in haemodialysis patients than that of CAPD patients (75% vs 13%, PϽ0.001). Although a number of factors such as autonomic dysfunction, increase in plasma volume, heart failure and sleep disorders have been implicated for abnormal circadian rhythm of BP in dialysis patients, the main reason of it was unclear. In our study, during the first day of monitoring, haemodialysis patients had a lesser dipper rate as compared with CAPD who had significantly higher BP and possibly hypervolaemia. Moreover, Chazot et al 22 reported from Tassin Center, more than half of the haemodialysis patients had an abnormal nocturnal dipping, despite none of the patients except one had been receiving antihypertensive medication. These findings suggested that abnormalities in the circadian rhythm of BP might not be associated with volume status of the patients and might be associated with some other uraemic or neurohumoral factors.
It has been reported that non-dipper patients has increased risk of target organ damage and mortality
